首页> Journal of ovarian research> The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial.

The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial.

导出 OA

翻译打印收藏纠错

第一作者： Hongyuan,Gu

第一单位： Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, 210009, Jiangsu, P.R. China.;Nanjing Gaochun People's Hospital, Nanjing, 211300, Jiangsu, P.R. China.

作者： Hongyuan,Gu ^[1] ; Rui,Zhou ^[2] ; Jing,Ni ^[2] ; Xia,Xu ^[3] ; Xianzhong,Cheng ^[2] ; Yan,Li ^[4] ; Xiaoxiang,Chen ^[5]

作者单位： Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, 210009, Jiangsu, P.R. China.;Nanjing Gaochun People's Hospital, Nanjing, 211300, Jiangsu, P.R. China. ^[1] Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, 210009, Jiangsu, P.R. China. ^[2] Department of Chemotherapy, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, 210009, Jiangsu, P.R. China. ^[3] The Medical College of Yangzhou University, Yangzhou, Jiangsu, P.R. China. ^[4] Department of Gynecologic Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, 210009, Jiangsu, P.R. China. cxxxxcyd@gmail.com. ^[5]

关键词 Epithelial ovarian cancer Platinum free interval Platinum sensitive recurrent ovarian cancer Secondary cytoreductive surgery Secondary neo-adjuvant chemotherapy Time to progression